191 related articles for article (PubMed ID: 35523582)
21. Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis.
Nardo G; Iennaco R; Fusi N; Heath PR; Marino M; Trolese MC; Ferraiuolo L; Lawrence N; Shaw PJ; Bendotti C
Brain; 2013 Nov; 136(Pt 11):3305-32. PubMed ID: 24065725
[TBL] [Abstract][Full Text] [Related]
22. Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
Apolloni S; Amadio S; Montilli C; Volonté C; D'Ambrosi N
Hum Mol Genet; 2013 Oct; 22(20):4102-16. PubMed ID: 23736299
[TBL] [Abstract][Full Text] [Related]
23. Modulation of astrocytic mitochondrial function by dichloroacetate improves survival and motor performance in inherited amyotrophic lateral sclerosis.
Miquel E; Cassina A; Martínez-Palma L; Bolatto C; Trías E; Gandelman M; Radi R; Barbeito L; Cassina P
PLoS One; 2012; 7(4):e34776. PubMed ID: 22509356
[TBL] [Abstract][Full Text] [Related]
24. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
[TBL] [Abstract][Full Text] [Related]
25. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
[TBL] [Abstract][Full Text] [Related]
26. In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1
Bonifacino T; Provenzano F; Gallia E; Ravera S; Torazza C; Bossi S; Ferrando S; Puliti A; Van Den Bosch L; Bonanno G; Milanese M
Neurobiol Dis; 2019 Sep; 129():79-92. PubMed ID: 31102766
[TBL] [Abstract][Full Text] [Related]
27. Neuroprotective Effects of Genistein in a SOD1-G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
Zhao Z; Fu J; Li S; Li Z
J Neuroimmune Pharmacol; 2019 Dec; 14(4):688-696. PubMed ID: 31321663
[TBL] [Abstract][Full Text] [Related]
28. Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1
MacLean M; Juranek J; Cuddapah S; López-Díez R; Ruiz HH; Hu J; Frye L; Li H; Gugger PF; Schmidt AM
J Neuroinflammation; 2021 Jun; 18(1):139. PubMed ID: 34130712
[TBL] [Abstract][Full Text] [Related]
29. Isoform-selective as opposed to complete depletion of fibroblast growth factor 2 (FGF-2) has no major impact on survival and gene expression in SOD1
Kefalakes E; Sarikidi A; Bursch F; Ettcheto M; Schmuck M; Rumpel R; Grothe C; Petri S
Eur J Neurosci; 2019 Sep; 50(6):3028-3045. PubMed ID: 30883949
[TBL] [Abstract][Full Text] [Related]
30. REEP1 Preserves Motor Function in SOD1
Qin S; You P; Yu H; Su B
Neurosci Bull; 2023 Jun; 39(6):929-946. PubMed ID: 36520405
[TBL] [Abstract][Full Text] [Related]
31. Targeting autotaxin impacts disease advance in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
Gento-Caro Á; Vilches-Herrando E; Portillo F; González-Forero D; Moreno-López B
Brain Pathol; 2022 May; 32(3):e13022. PubMed ID: 34585475
[TBL] [Abstract][Full Text] [Related]
32. Early upregulation of cytosolic phospholipase A
Malada Edelstein YF; Solomonov Y; Hadad N; Alfahel L; Israelson A; Levy R
J Neuroinflammation; 2021 Nov; 18(1):274. PubMed ID: 34823547
[TBL] [Abstract][Full Text] [Related]
33. Early deficits in GABA inhibition parallels an increase in L-type Ca
Venugopal S; Ghulam-Jhelani Z; Ahn IS; Yang X; Wiedau M; Simmons D; Chandler SH
Neurobiol Dis; 2023 Feb; 177():105992. PubMed ID: 36623607
[TBL] [Abstract][Full Text] [Related]
34. Sex-Dependent Changes to the Intestinal and Hepatic Abundance of Drug Transporters and Metabolizing Enzymes in the SOD1
Koehn LM; Steele JR; Schittenhelm RB; Turner BJ; Nicolazzo JA
Mol Pharm; 2024 Apr; 21(4):1756-1767. PubMed ID: 38415587
[TBL] [Abstract][Full Text] [Related]
35. MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis.
Zhang X; Chen S; Song L; Tang Y; Shen Y; Jia L; Le W
Autophagy; 2014 Apr; 10(4):588-602. PubMed ID: 24441414
[TBL] [Abstract][Full Text] [Related]
36. Different human copper-zinc superoxide dismutase mutants, SOD1G93A and SOD1H46R, exert distinct harmful effects on gross phenotype in mice.
Pan L; Yoshii Y; Otomo A; Ogawa H; Iwasaki Y; Shang HF; Hadano S
PLoS One; 2012; 7(3):e33409. PubMed ID: 22438926
[TBL] [Abstract][Full Text] [Related]
37. Nicotinamide Riboside Enhances Mitochondrial Proteostasis and Adult Neurogenesis through Activation of Mitochondrial Unfolded Protein Response Signaling in the Brain of ALS SOD1
Zhou Q; Zhu L; Qiu W; Liu Y; Yang F; Chen W; Xu R
Int J Biol Sci; 2020; 16(2):284-297. PubMed ID: 31929756
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic Treatment of Superoxide Dismutase 1 (G93A) Amyotrophic Lateral Sclerosis Model Mice with Medical Ozone Decelerates Trigeminal Motor Neuron Degeneration, Attenuates Microglial Proliferation, and Preserves Monocyte Levels in Mesenteric Lymph Nodes.
Bette M; Cors E; Kresse C; Schütz B
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328829
[TBL] [Abstract][Full Text] [Related]
39. The NADPH oxidase pathway is dysregulated by the P2X7 receptor in the SOD1-G93A microglia model of amyotrophic lateral sclerosis.
Apolloni S; Parisi C; Pesaresi MG; Rossi S; Carrì MT; Cozzolino M; Volonté C; D'Ambrosi N
J Immunol; 2013 May; 190(10):5187-95. PubMed ID: 23589615
[TBL] [Abstract][Full Text] [Related]
40. Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Bryson JB; Hobbs C; Parsons MJ; Bosch KD; Pandraud A; Walsh FS; Doherty P; Greensmith L
Hum Mol Genet; 2012 Sep; 21(17):3871-82. PubMed ID: 22678056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
